Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma

Journal of Oral Pathology and Medicine

Volumn 40, Issue 2, 2011, Pages 187-193

  Park, Jong Hwan ^a   Yoon, Hyo Eun ^b   Kim, Dong Jae ^c   Kim, Soo A ^d   Ahn, Sang Gun ^b   Yoon, Jung Hoon ^b  

^a Konyang University   (South Korea)

^b Chosun University   (South Korea)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Dongguk University   (South Korea)

Author keywords

Flagellin; Invasion; Migration; Salivary gland carcinoma; Toll like receptor

Indexed keywords

FLAGELLIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MATRIGEL; MYELOID DIFFERENTIATION FACTOR 88; PROTHROMBIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5;

ARTICLE; CANCER INVASION; CELL ASSAY; CELL INVASION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND CARCINOMA;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MOVEMENT; CHEMOTAXIS; COLLAGEN; DRUG COMBINATIONS; FLAGELLIN; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LAMININ; NEOPLASM INVASIVENESS; PROTEOGLYCANS; SALIVARY GLAND NEOPLASMS; TOLL-LIKE RECEPTOR 5;

EID: 79251565525     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00929.x     Document Type: Article

References (42)

1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
2. Liu B, Dai J, Zheng H, et al. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc Natl Acad Sci U S A 2003; 100: 15824-9.
3. Vabulas RM, Wagner H, Schild H. Heat shock proteins as ligands of Toll-like receptors. Curr Top Microbiol Immunol 2002; 270: 169-84.
4. Taylor KR, Trowbridge JM, Rudisill JA, et al. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004; 279: 17079-84.
5. Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195: 99-111.
6. Johnson GB, Brunn GJ, Kodaira Y, et al. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002; 168: 5233-9.
7. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167: 2887-94.
8. Okamura Y, Watari M, Jerud ES, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001; 276: 10229-33.
9. Guillot L, Balloy V, Mccormack FX, et al. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 2002; 168: 5989-92.
10. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7.
11. Lee MS, Kim YJ. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 2007; 76: 447-80.
12. Rakoff-nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer 2009; 9: 57-63.
13. Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005; 65: 5009-14.
14. Kim S, Takahashi H, Lin WW, et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009; 457: 102-6.
15. Harmey JH, Bucana CD, Lu W, et al. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer 2002; 101: 415-22.
16. Ilvesaro JM, Merrell MA, Swain TM, et al. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 2007; 67: 774-81.
17. Merrell MA, Ilvesaro JM, Lehtonen N, et al. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 2006; 4: 437-47.
18. Kelly MG, Alvero AB, Chen R, et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 2006; 66: 3859-68.
19. Wang JH, Manning BJ, Wu QD, et al. Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism. J Immunol 2003; 170: 795-804.
20. Yuan ZQ, Feldman RI, Sussman GE, et al. AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol Chem 2003; 278: 23432-40.
21. Hua D, Liu MY, Cheng ZD, et al. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Mol Immunol 2009; 46: 2876-84.
22. Shaykhiev R, Behr J, Bals R. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PLoS ONE 2008; 3: e1393.
23. Xie W, Wang Y, Huang Y, et al. Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells. Biochem Biophys Res Commun 2009; 379: 1027-32.
24. Killeen SD, Wang JH, Andrews EJ, et al. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system. Br J Cancer 2009; 100: 1589-602.
25. Etges A, Nunes FD, Ribeiro KC, et al. Immunohistochemical expression of retinoblastoma pathway proteins in normal salivary glands and in salivary gland tumours. Oral Oncol 2004; 40: 326-31.
26. Milano A, Longo F, Basile M, et al. Recent advances in the treatment of salivary gland cancers: emphasis on molecular targeted therapy. Oral Oncol 2007; 43: 729-34.
27. Prenen H, Kimpe M, Nuyts S. Salivary gland carcinomas: molecular abnormalities as potential therapeutic targets. Curr Opin Oncol 2008; 20: 270-4.
28. Barnes L, Everson JW, Reichart P. World Health Organization classification of tumours. Lyon: IARC Press, 2005.
29. Spiro RH. Management of malignant tumors of the salivary glands. Oncology (Williston Park) 1998; 12: 671-80. discussion 683.
30. Kawakami A, Nakashima K, Tamai M, et al. Toll-like receptor in salivary glands from patients with Sjogren's syndrome: functional analysis by human salivary gland cell line. J Rheumatol 2007; 34: 1019-26.
31. Spachidou MP, Bourazopoulou E, Maratheftis CI, et al. Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren's syndrome. Clin Exp Immunol 2007; 147: 497-503.
32. Shrestha P, Sumitomo S, Lee CH, et al. Tenascin: growth and adhesion modulation - extracellular matrix degrading function: an in vitro study. Eur J Cancer B Oral Oncol 1996; 32B: 106-13.
33. Hidalgo K, Rojas IG, Penissi AB, et al. TNFalpha increases in vitro migration of human HPV18-positive SW756 cervical carcinoma cells. Biocell 2005; 29: 303-11.
34. Lin TH, Kuo HC, Chou FP, et al. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 2008; 8: 58.
35. Wolska A, Lech-Maranda E, Robak T. Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cell Mol Biol Lett 2009; 14: 248-72.
36. Kundu SD, Lee C, Billips BK, et al. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 2008; 68: 223-9.
37. Chochi K, Ichikura T, Kinoshita M, et al. Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells. Clin Cancer Res 2008; 14: 2909-17.
38. Lehner M, Bailo M, Stachel D, et al. Caspase-8 dependent apoptosis induction in malignant myeloid cells by TLR stimulation in the presence of IFN-alpha. Leuk Res 2007; 31: 1729-35.
39. Travassos LH, Girardin SE, Philpott DJ, et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 2004; 5: 1000-6.
40. Inohara N, Chamaillard M, McDonald C, et al. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005; 74: 355-83.
41. Kim WY, Lee JW, Choi JJ, et al. Increased expression of Toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer 2008; 18: 300-5.
42. Rhee SH, Im E, Pothoulakis C. Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer. Gastroenterology 2008; 135: 518-28.